Ajanta Pharma Limited(IN:AJANTPHARM)
₹3,358.70+74.30 (+2.26%)
IN:AJANTPHARM
Ajanta Pharma Limited financials statements
₹3,358.70
At close:+74.30 (+2.26%)
Want to see IN:AJANTPHARM full AI Analyst Report?
Ajanta Pharma Limited (AJANTPHARM) Income Statement
6 Followers
Ajanta Pharma Limited Income Statement
Last quarter (Q2 2027), Ajanta Pharma Limited's total revenue was ₹17.94B, an increase of 32.53% from the same quarter last year. In Q2, Ajanta Pharma Limited's net income was ₹3.88B. See Ajanta Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| ₹ 54.53B | ₹ 45.88B | ₹ 41.62B | ₹ 37.08B | ₹ 32.84B | |
| ₹ 28.05B | ₹ 34.60B | ₹ 30.46B | ₹ 25.91B | ₹ 23.97B | |
| ₹ 14.80B | ₹ 23.32B | ₹ 20.01B | ₹ 19.11B | ₹ 15.86B | |
| Depreciation and Amortization | ₹ 1.73B | ₹ 1.44B | ₹ 1.35B | ₹ 1.31B | ₹ 1.25B |
| ₹ 15.67B | ₹ 13.54B | ₹ 12.57B | ₹ 8.82B | ₹ 10.45B | |
| ₹ 13.25B | ₹ 11.28B | ₹ 10.46B | ₹ 6.80B | ₹ 8.12B | |
| ₹ 529.20M | ₹ 607.00M | ₹ 682.90M | ₹ 654.90M | ₹ 976.00M | |
| ₹ 13.78B | ₹ 11.89B | ₹ 11.14B | ₹ 7.45B | ₹ 9.09B | |
| ₹ 10.56B | ₹ 9.20B | ₹ 8.16B | ₹ 5.88B | ₹ 7.13B | |
| Per Share Metrics | |||||
| Basic EPS | ₹ 84.53 | ₹ 73.56 | ₹ 64.82 | ₹ 45.89 | ₹ 54.97 |
| Diluted EPS | ₹ 84.53 | ₹ 73.53 | ₹ 64.77 | ₹ 45.89 | ₹ 54.96 |
| Weighted Average Shares Outstanding | 124.93M | 125.17M | 125.92M | 128.12M | 129.66M |
| Weighted Average Shares Outstanding (Diluted) | 124.93M | 125.17M | 126.01M | 128.12M | 129.66M |
Currency in INR

